Arctx Medical Receives IDE approval from FDA for a Pivotal Clinical Trial of its ACC Kit for the Treatment of Acute Pancreatitis, Announces New Leadership
Summary by The Courier Express
23 Articles
23 Articles

+22 Reposted by 22 other sources
Arctx Medical Receives IDE approval from FDA for a Pivotal Clinical Trial of its ACC Kit for the Treatment of Acute Pancreatitis, Announces New Leadership
RALEIGH, N.C., Aug. 26, 2025 /PRNewswire/ -- Arctx Medical, Inc. ("Arctx", "the Company"), a clinical-stage medical device company, announced today that it has achieved three significant milestones:
Coverage Details
Total News Sources23
Leaning Left1Leaning Right4Center7Last UpdatedBias Distribution58% Center
Bias Distribution
- 58% of the sources are Center
58% Center
C 58%
R 33%
Factuality
To view factuality data please Upgrade to Premium